FDA extends review of Pennsaid(R) diclofenac sodium topical solution
...ent practices of a small number of large public and private insurers, cost-containment efforts of customers, purchasing groups, third-party payers and governmental organizations, intellectual property rights disputes, complex and costly regulation, including healthcare fraud and abuse regulations, manufacturing o...Samarion Announces Partnership With Adesta to Install the SamarionSolution Nationwide
...tand-alone or integrated communication networks and electronic security systems. For nearly two decades, Adesta has offered commercial, industrial and governmental clients an efficient single point of contact for all their project issues. A trusted partner to customers and suppliers around the world, Adesta takes...West Announces Second Quarter 2009 Results
...ions, including the effects of delays and cost increases associated with construction, availability and cost of capital goods, and necessary internal, governmental and customer approvals of planned and completed projects, and the demand for goods to be produced in new facilities; dependence on third-part...Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
... information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products or new technology for ...FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors c...INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder
...by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors c...Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009
...the potential risks and uncertainties that could cause actual results to differ from the results predicted include, without limitation, commercial and governmental reimbursement decisions, compliance and regulatory risks, financial risks, the Company's ability to hire personnel and manage its growth and the compe...Nephros, Inc. Completes $1.25 Million Private Placement
...ble: (i) to obtain additional funding when needed or on favorable terms; (ii) to continue as a going concern; (iii) to obtain appropriate or necessary governmental approvals to achieve its business plan or effectively market its products; (iv) to have its technologies and products accepted in current or future ta...Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors c...Cyberonics Provides Update on Depression Post-Approval Study
...mates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our inter...nal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto and other risks detailed from...Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
...lity to successfully integrate acquired businesses; our ability to form and implement alliances; challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration and foreign gover...CLIA-Certified Diagnostic Laboratory
Description:...ces and pre-clinical trials services. Our clients include a prestigious list of major universities, leaders in the field of commercial bioscience and governmental agencies....DOE-funded research projects win 46 R&D 100 Awards for 2009
...to perform large-scale numerical simulations of physical phenomena rapidly and efficiently. The ability to perform simulations allows corporations and governmental agencies to replace costly and dangerous experiments and prototypes. Simulations have led to many new products as well as improvements in existing pro...Genetic tests advertised directly to the consumer
...n order for the consumer to have a positive experience with choosing genetic testing from advertising, clinical pharmacologists believe that effective governmental oversight is imperative, along with assistance from professional clinicians. Clinical pharmacologists should also help prepare consumers for possi...University of Houston Site of Regional Center of Excellence
...ch and teaching institution, is home to more than 40 research centers and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse research university in the country, stands at the forefront of education, research and service with more than 36,000 s...Can organic cropping systems be as profitable as conventional systems?
...rganic systems. And to our surprise, including risk premiums into the evaluation did not change the ranking of the systems. This study indicates that governmental policy that supports mono-culture systems is outdated and support should be shifted to programs that promote crop rotations and organic farming practi...Can organic cropping systems be as profitable as conventional systems?
...rganic systems. And to our surprise, including risk premiums into the evaluation did not change the ranking of the systems. This study indicates that governmental policy that supports mono-culture systems is outdated and support should be shifted to programs that promote crop rotations and organic farming practi...Climate change aims need to be better integrated
... Dr. Per Mickwitz, from the Finnish Environment Institute (SYKE), said, "Although the inclusion of climate change mitigation and adaptation in general governmental programmes and strategies has substantially increased in recent years, much more is needed in terms of integrating climate issues into specific policy...Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
...or security, lighting and access control for the commercial, industrial and governmental markets by extending our product line to include DRSA's marine and industri...curity, access, lighting and control systems for industrial, commercial and governmental market. EXGI's recently acquired Hawk Biometric Technologies subsidiary is...Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
...or security, lighting and access control for the commercial, industrial and governmental markets by extending our product line to include DRSA's marine and industri...curity, access, lighting and control systems for industrial, commercial and governmental market. EXGI's recently acquired Hawk Biometric Technologies subsidiary is...SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy
As an attorney who works with several technology-based companies, I frequently receive questions about how to obtain outside financing. One source that is often overlooked is government funding through the federal Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) ...KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...on, including with respect to product liability or securities litigation; (24) the informal inquiry initiated by the SEC and any related or additional governmental investigative or enforcement proceedings, including actions by the FDA and the U.S. Department of Justice, all as more fully described in the Company'...Schering-Plough Shareholders Approve Merger With Merck
...ng to marketed products or pipeline projects; media and societal reaction to such developments; and the ability of Schering-Plough and Merck to obtain governmental approvals of the merger on the proposed terms and schedule. For further details of these and other risks and uncertainties that may impact forward-lo...Novavax Reports Second Quarter 2009 Financial Results
...ed key executives to support the future growth of the company. New appointments include Mr. John Trizzino as Senior Vice President, International and governmental Affairs, and Mr. Fredrick W. Driscoll as Vice President, Chief Financial Officer and Treasurer. Achieved a major production milestone in the Pa...Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
...opment plans once they are developed." McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek governmental grants from the National Institutes of Health ("NIH"), the National Institute on Drug Abuse, and other agencies that operate under the NIH umbrella, f...